Sadowski Martin, Mawson Amanda, Baker Rohan, Sarcevic Boris
Cell Cycle and Cancer Unit, St. Vincent's Institute of Medical Research, Fitzroy, Melbourne, VIC 3065, Australia.
Biochem J. 2007 Aug 1;405(3):569-81. doi: 10.1042/BJ20061812.
The ubiquitin-conjugating enzyme Cdc34 (cell division cycle 34) plays an essential role in promoting the G1-S-phase transition of the eukaryotic cell cycle and is phosphorylated in vivo. In the present study, we investigated if phosphorylation regulates Cdc34 function. We mapped the in vivo phosphorylation sites on budding yeast Cdc34 (yCdc34; Ser207 and Ser216) and human Cdc34 (hCdc34 Ser203, Ser222 and Ser231) to serine residues in the acidic tail domain, a region that is critical for Cdc34's cell cycle function. CK2 (protein kinase CK2) phosphorylates both yCdc34 and hCdc34 on these sites in vitro. CK2-mediated phosphorylation increased yCdc34 ubiquitination activity towards the yeast Saccharomyces cerevisiae Sic1 in vitro, when assayed in the presence of its cognate SCFCdc4 E3 ligase [where SCF is Skp1 (S-phase kinase-associated protein 1)/cullin/F-box]. Similarly, mutation of the yCdc34 phosphorylation sites to alanine, aspartate or glutamate residues altered Cdc34-SCFCdc4-mediated Sic1 ubiquitination activity. Similar results were obtained when yCdc34's ubiquitination activity was assayed in the absence of SCFCdc4, indicating that phosphorylation regulates the intrinsic catalytic activity of Cdc34. To evaluate the in vivo consequences of altered Cdc34 activity, wild-type yCdc34 and the phosphosite mutants were introduced into an S. cerevisiae cdc34 deletion strain and, following synchronization in G1-phase, progression through the cell cycle was monitored. Consistent with the increased ubiquitination activity in vitro, cells expressing the phosphosite mutants with higher catalytic activity exhibited accelerated cell cycle progression and Sic1 degradation. These studies demonstrate that CK2-mediated phosphorylation of Cdc34 on the acidic tail domain stimulates Cdc34-SCFCdc4 ubiquitination activity and cell cycle progression.
泛素结合酶Cdc34(细胞分裂周期34)在促进真核细胞周期的G1期向S期转变过程中发挥着至关重要的作用,且在体内会发生磷酸化。在本研究中,我们探究了磷酸化是否调节Cdc34的功能。我们将芽殖酵母Cdc34(yCdc34;Ser207和Ser216)以及人类Cdc34(hCdc34 Ser203、Ser222和Ser231)的体内磷酸化位点定位到酸性尾部结构域的丝氨酸残基上,该区域对Cdc34的细胞周期功能至关重要。蛋白激酶CK2在体外可使yCdc34和hCdc34在这些位点发生磷酸化。在其同源SCFCdc4 E3连接酶[其中SCF是Skp1(S期激酶相关蛋白1)/cullin/F盒]存在的情况下进行体外检测时,CK2介导的磷酸化增加了yCdc34对酿酒酵母Sic1的泛素化活性。同样,将yCdc34的磷酸化位点突变为丙氨酸、天冬氨酸或谷氨酸残基会改变Cdc34 - SCFCdc4介导的Sic1泛素化活性。在不存在SCFCdc4的情况下检测yCdc34的泛素化活性时也得到了类似结果,这表明磷酸化调节Cdc34的内在催化活性。为了评估Cdc34活性改变在体内的影响,将野生型yCdc34和磷酸化位点突变体导入酿酒酵母cdc34缺失菌株中,并在G1期同步化后,监测细胞周期进程。与体外泛素化活性增加一致,表达具有较高催化活性的磷酸化位点突变体的细胞表现出加速的细胞周期进程和Sic1降解。这些研究表明,CK2介导的Cdc34在酸性尾部结构域的磷酸化刺激了Cdc34 - SCFCdc4泛素化活性和细胞周期进程。